CLAZAKIZUMAB® (ANTI-IL-6) FOR DESENSITIZATION OF HIGHLY-HLA SENSITIZED PATIENTS AWAITING KIDNEY TRANSPLANT (NCT03380962). Issue 3 (September 2020) - Vo, Ashley; Ammerman, Noriko; Huang, Edmund; Toyoda, Mieko; Ge, Shili; Peng, Alice; Najjar, Reiad; Williamson, Summer; Myers, Catherine; Sethi, Supreet; Lim, Kathlyn; Choi, Jua; et al.